Skip to main content
Clinical Trials/NCT02721602
NCT02721602
Completed
N/A

Families Preventing Diabetes Together

University of Minnesota1 site in 1 country7 target enrollmentFebruary 2016

Overview

Phase
N/A
Intervention
Not specified
Conditions
Type 2 Diabetes
Sponsor
University of Minnesota
Enrollment
7
Locations
1
Primary Endpoint
Feasibility of the study measured via the ability to successfully recruit 30-40 families for the study.
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The current study proposes to study the feasibility and acceptability of the Families Preventing Diabetes Together Intervention among 40 families who have one parent diagnosed with type 2 diabetes and at least 1 child between the ages of 5-14 years of age. Successful recruitment, measurement and randomization of patients and their families will provide data for our aim of assessing feasibility. Patient and family participation in the intervention and feedback via the post-intervention surveys will provide data for our aim of acceptability.

Detailed Description

The current study is a randomized controlled trial with 40 families. Twenty families will be randomly assigned to receive usual care consisting of diabetes education delivered through Fairview Health Services. An additional 20 families will be randomized to a family-based, in-person program that focuses on nutrition education, the development of meal planning and cooking skills and promotion of healthful eating for families; the program will augment usual care and diabetes education received from Fairview Health Services for the parent with diabetes. Parents with diabetes who are randomized to the intervention group will also participate in one goal-setting phone call with intervention staff at one point during the intervention program. Adult patients and their families will be recruited in two ways: 1. from Fairview Health Service's clinics in the North metropolitan area with the assistance of Fairview Health Service diabetes educators, and 2. through MyChart messages informing them about the study. Adults between the ages of 25 and 55 years who have a diagnosis of Type 2 diabetes, who have participated in at least some diabetes education through Fairview Health Services, and who have at least one child between the ages of 7-12 years of age will be invited to participate in the study. Successful recruitment, measurement and randomization of patients and their families will provide data for our aim of assessing feasibility. Patient and family participation in the intervention and feedback via the post-intervention surveys will provide data for our aim of acceptability.

Registry
clinicaltrials.gov
Start Date
February 2016
End Date
June 30, 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Parent with Type 2 diabetes
  • At least 1 child between the ages of 7-12
  • Parent has completed at least some Diabetes Education through Fairview Health System

Exclusion Criteria

  • Parent with Type 2 diabetes does not speak or read in English
  • No parents with Type 2 diabetes or no children ages 7-12 years
  • Parent with Type 2 diabetes has not completed at least some Diabetes Education

Outcomes

Primary Outcomes

Feasibility of the study measured via the ability to successfully recruit 30-40 families for the study.

Time Frame: up to 6 months

Ability to successfully recruit 30- 40 families in the study will determine feasibility.

Feasibility of the study measured via the ability to successfully measure 100% of the adults and 80% of the children in enrolled families at baseline measurements.

Time Frame: up to 6 months

Ability to successfully measure 100% of recruited adults and 80% of children in enrolled families at baseline measurements will determine feasibility.

Feasibility of the study measured via the ability to successfully retain 85% of the enrolled families over the course of the study measured by their participate in post-intervention measurements.

Time Frame: up to 6 months

Feasibility of the study measured via the ability to successfully retain 85% of the enrolled families over the course of the study measured by their participate in post-intervention measurements.

Acceptability of the intervention measured via family participation rates (families attend at least 70% of the sessions).

Time Frame: up to 6 months

Family participation in the intervention (attending at least 70% of sessions) will determine acceptability.

Acceptability of the intervention measured via family feedback indicating at least 90% approve of the sessions on post-intervention surveys.

Time Frame: up to 6 months

Acceptability of the intervention measured via family feedback indicating at least 90% approve of the sessions on post-intervention surveys.

Secondary Outcomes

  • Blood glucose control in parent with Type 2 diabetes(up to 6 months)
  • Child BMIz(up to 6 months)

Study Sites (1)

Loading locations...

Similar Trials